Alzheimer’s Drug Demonstrates Good Tolerability Beyond Clinical Trials
In 2023, the Food and Drug Administration (FDA) rendered a groundbreaking decision by approving lecanemab, a novel therapeutic agent aimed ...
Tag: early-stage Alzheimer’s management
POPULAR NEWS
-
Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission
-
New Study Reveals the Science Behind Exercise and Weight Loss
-
New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases
-
Revolutionizing Optimization: Deep Learning for Complex Systems